Links between mTOR and the immunoproteasome: Therapeutic targets for cardiac hypertrophy?

被引：2
|
作者：
Ackermann, Maegen A. [1 ]
机构：
[1] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Wexner Coll Med, Columbus, OH 43210 USA
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2015年 / 89卷
关键词：
UBIQUITIN-PROTEASOME SYSTEM; NF-KAPPA-B; MAMMALIAN TARGET; CARDIOMYOCYTE SURVIVAL; MYOCARDIAL-ISCHEMIA; PROTEIN-SYNTHESIS; DOWN-REGULATION; LIFE-SPAN; RAPAMYCIN; INHIBITION;
D O I：
10.1016/j.yjmcc.2015.09.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 115
页数：3
相关论文
共 50 条
  • [31] Crosstalk between Autophagy and Apoptosis: Potential and Emerging Therapeutic Targets for Cardiac Diseases
    Li, Meng
    Gao, Ping
    Zhang, Junping
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (03):
  • [32] Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway
    Chen, Xing
    Jiang, Xingzuan
    Cheng, Chuanfang
    Chen, Jing
    Huang, Shuyan
    Xu, Miqing
    Liu, Shiming
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (04) : 463 - 473
  • [33] Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway
    Xing Chen
    Xingzuan Jiang
    Chuanfang Cheng
    Jing Chen
    Shuyan Huang
    Miqing Xu
    Shiming Liu
    Cardiovascular Drugs and Therapy, 2020, 34 : 463 - 473
  • [34] Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy
    Proud, CG
    CARDIOVASCULAR RESEARCH, 2004, 63 (03) : 403 - 413
  • [35] Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia
    Tong, Wing-Hang
    Ollivierre, Hayden
    Noguchi, Audrey
    Ghosh, Manik C.
    Springer, Danielle A.
    Rouault, Tracey A.
    HELIYON, 2022, 8 (08)
  • [36] mTOR INHIBITION BLOCKS CARDIAC HYPERTROPHY AFTER RENAL MASS REDUCTION
    Rovira, Jordi
    Arellano, Marcelo
    Carreras, Joaquim
    Moya, Daniel
    Banon-Maneus, Elisenda
    Ramirez-Bajo, Maria J.
    Quintana, Luis
    Revuelta, Ignacio
    Diekmann, Fritz
    Campistol, Josep M.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 308 - 308
  • [37] Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload
    Chen, Chen
    Zou, Lei-Xin
    Lin, Qiu-Yue
    Yan, Xiao
    Bi, Hai-Lian
    Xie, Xin
    Wang, Shuai
    Wang, Qing-Shan
    Zhang, Yun-Long
    Li, Hui-Hua
    REDOX BIOLOGY, 2019, 20 : 390 - 401
  • [38] Silencing Survivin: a Key Therapeutic Strategy for Cardiac Hypertrophy
    Kusmic, Claudia
    Vizzoca, Alessio
    Taranta, Monia
    Tedeschi, Lorena
    Gherardini, Lisa
    Pelosi, Gualtiero
    Giannetti, Ambra
    Tombelli, Sara
    Grimaldi, Settimio
    Baldini, Francesco
    Domenici, Claudio
    Trivella, Maria Giovanna
    Cinti, Caterina
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2022, 15 (02) : 391 - 407
  • [39] Alamandine, a molecule of therapeutic interest against cardiac hypertrophy
    Coulibaly, Aboubacar Sidiki Kibarou
    Deriaz, Caroline
    Robin, Philippe
    M S-MEDECINE SCIENCES, 2020, 36 (02): : 171 - +
  • [40] Silencing Survivin: a Key Therapeutic Strategy for Cardiac Hypertrophy
    Claudia Kusmic
    Alessio Vizzoca
    Monia Taranta
    Lorena Tedeschi
    Lisa Gherardini
    Gualtiero Pelosi
    Ambra Giannetti
    Sara Tombelli
    Settimio Grimaldi
    Francesco Baldini
    Claudio Domenici
    Maria Giovanna Trivella
    Caterina Cinti
    Journal of Cardiovascular Translational Research, 2022, 15 : 391 - 407
12345